Slide background


US WorldMeds held a groundbreaking ceremony on Friday, July 12th to officially mark the beginning of construction on their new US WorldMeds Corporate Headquarters in Louisville, Kentucky. 

There were over 75 people on hand for the ceremony, including Louisville Mayor Greg Fischer.  "It's very symbolic when you plant roots like this and put up a tremendous building, it really says something about we're here to stay, we're here to grow and keep growing a great international company."

During the ceremony CEO Breckinridge Jones introduced the construction team that will be working together to build the new US WorldMeds Headquarters.  The architectural team Potter & Associates Architects and the Construction Managers Branscum Construction Company, Inc.

The Louisville-based pharmaceutical, US WorldMeds Headquarters will be located on Springdale Road near The Summit shopping center.  The new headquarters will be a 45,000 square foot space with 3 stories.  It will be very energy efficient with LED lighting and efficient heating system.  The unique design will consist of large dome skylight and curved glass entryway to sure ensure a bright and open.  Construction will begin early fall 2013 and finish early 2015.

US WorldMeds

US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products.

Organized on March 23, 2001, by current CEO Paul Breckinridge "Breck" Jones, US WorldMeds holds true to our founder's original vision to become a substantial global operating enterprise while remaining closely-held and able to capitalize on local and experienced talent. US WorldMeds remains committed to continuing to expand into a major corporate citizen and a formidable source of innovative pharmaceutical products and high-quality jobs for generations to come - both in our Louisville headquarters and our satellite offices and manufacturing facilities.

While starting at home and planting deep roots may have been our founding principles, US WorldMeds' mission now stretches far beyond city, state or national borders. US WorldMeds continually strives to identify specialty products for niche patient groups and increase access to those treatments across the globe. The company has built a platform for success on two primary strengths: sound science and targeted commercialization.

To fulfill its mission, US WorldMeds will strive to seek well-positioned strategic partnerships; asset divestitures and acquisition or licensing opportunities to expand our portfolio; and to open doors to new domestic and international markets, all to create greater access to care for the patients we serve.

US WorldMeds Groundbreaking 008 US WorldMeds Groundbreaking 014

What Clients are Saying About Branscum

“If we had any questions or concerns, they were answered promptly and any problems were resolved just as quickly.”

—Betty K. Howell, Sunrise Manor